Company Information
Address Corridor Pharmaceuticals, Inc.
2330 W JOPPA RD, STE 330
LUTHERVILLE, MD, 21093-4690


DUNS: 824770791

# of Employees: 0

Ownership Information

HUBZone Owned: N

Socially and Economically Disadvantaged: N

Woman Owned: N

Award Charts

Award Listing

  1. Targeting endothelial arginase to treat diabetes-associated vascular dysfunction

    Amount: $365,333.00

    DESCRIPTION (provided by applicant): The product that will result from this STTR is ABH (2(S)-amino-6-boronohexanoic acid), a potent small molecule inhibitor of the enzyme arginase, for treating vasc ...

    STTRPhase I2010Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government